Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis
Anna De Benedetto(University of Rochester Medicine), Lisa A. Beck(University of Rochester Medicine), David C. Johnson(Johnson & Johnson (United States)), Donald Y.M. Leung(Boston Children's Hospital), Mark K. Slifka(Oregon Health & Science University), Mark Boguniewicz(University of Colorado Denver), Richard L. Gallo(University of California San Diego), Steve N. Georas(University of Rochester Medicine), Lynda C. Schneider(Boston Children's Hospital), Tissa Hata(University of California San Diego), Jon M. Hanifin(Oregon Health & Science University), Kathleen C. Barnes(Johns Hopkins University), I‐Hsin Kuo(University of Rochester Medicine), Nicholas Rafaels(Johns Hopkins University)
Cited by 105
Related Papers
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
|The Journal of Clinical Endocrinology & Metabolism|2010|4k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k